Canada Insulin Delivery Devices Market, By Insulin Delivery Devices ((Insulin Pump (Insulin Pump Device, Insulin Infusion Sets, and Insulin Reservoirs), Insulin Syringes, Insulin Disposable Pens, Insulin Cartridges in Reusable Pens, and Insulin Jet Injectors)) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Jun 2022

Code : CMI5048

Pages :170

Formats :

Excel and PDF

Industry : Medical Devices

Canada Insulin Delivery Devices MarketSize and Trends

Figure 1. Canada Insulin Delivery Devices Market Share (%), by Insulin Delivery Devices, 2021

Market Statistics:

The Canada insulin delivery devices market was valued at US$ 1,142.4 Mn in 2021 and is forecast to reach a value of US$ 1,406.6 Mn by 2028 at a CAGR of 3.0% between 2022 and 2028.

Figure 2. Canada Insulin Delivery Devices Market Share (%) in Terms of Value, by Insulin Pump, 2021

Market Trends/Key Takeaways:

Frequent approvals and launches of novel products is expected to aid in the growth of the Canada insulin delivery devices market. For instance, in December 2020, Medtronic Canada received a licence from Health Canada for its MiniMed 770G insulin pump system, offering hybrid closed loop technology, with the added benefits of smartphone connectivity & expanded age indication to children as young as two years.
Players in the market are adopting various strategies to strengthen their product portfolio, in turn is expected to propel growth of the Canada insulin delivery devices market. For instance, in May 2021, to help streamline diabetes management, Eli Lilly and Company signed strategic international agreements with Roche, myDiabby Healthcare, Glooko Inc., and DexCom, Inc., to advance connected solutions and streamline care for people living with diabetes.